This inventor holds 1 USPTO granted patent. Top assignee: Kinaform Technology, Inc.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: The Innovations of David R Blazek
Introduction
David R Blazek is an accomplished inventor based in Columbus, OH. He is known for his significant contributions to the pharmaceutical field, particularly in the development of drug delivery systems. His innovative approach has led to the creation of a unique sustained-release pharmaceutical preparation.
Latest Patents
One of David R Blazek's notable patents is for a delayed, sustained-release propranolol pharmaceutical preparation. This invention features a water-soluble drug core that is surrounded by a hydratable diffusion barrier. This barrier is designed to delay drug release for approximately 2-10 hours. The formulation includes a film-forming polymer, such as an acrylic resin or ethyl cellulose, combined with additives that control the rate of hydration and permeability. This innovative preparation allows for improved therapeutic outcomes in patients requiring propranolol.
Career Highlights
David R Blazek has made significant strides in his career, particularly through his work at Kinaform Technology, Inc. His expertise in pharmaceutical formulations has positioned him as a key player in the industry. His dedication to research and development has resulted in advancements that benefit both healthcare providers and patients.
Collaborations
Throughout his career, David has collaborated with notable professionals in the field, including Brent D Massmann and the late Herman J Eichel. These collaborations have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
David R Blazek's contributions to the pharmaceutical industry through his innovative patent demonstrate his commitment to improving drug delivery systems. His work continues to influence the field and enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile